Future Financial Wealth Managment LLC lessened its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 25.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,452 shares of the company’s stock after selling 1,184 shares during the quarter. Future Financial Wealth Managment LLC’s holdings in Johnson & Johnson were worth $541,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Moneta Group Investment Advisors LLC increased its stake in Johnson & Johnson by 90,144.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 54,386,720 shares of the company’s stock worth $9,607,414,000 after acquiring an additional 54,326,454 shares during the last quarter. Norges Bank acquired a new stake in Johnson & Johnson during the fourth quarter worth $4,609,399,000. Journey Strategic Wealth LLC increased its stake in Johnson & Johnson by 161,420.2% during the second quarter. Journey Strategic Wealth LLC now owns 7,276,483 shares of the company’s stock worth $1,204,404,000 after acquiring an additional 7,271,978 shares during the last quarter. Morgan Stanley increased its stake in Johnson & Johnson by 12.0% during the fourth quarter. Morgan Stanley now owns 42,224,521 shares of the company’s stock worth $7,458,962,000 after acquiring an additional 4,521,062 shares during the last quarter. Finally, Barclays PLC increased its stake in Johnson & Johnson by 61.0% during the second quarter. Barclays PLC now owns 11,287,765 shares of the company’s stock worth $1,868,351,000 after acquiring an additional 4,278,512 shares during the last quarter. Institutional investors and hedge funds own 69.55% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on JNJ. Cantor Fitzgerald reissued an “overweight” rating and set a $215.00 target price on shares of Johnson & Johnson in a research note on Wednesday, March 13th. Wells Fargo & Company cut Johnson & Johnson from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $170.00 to $163.00 in a research note on Wednesday, December 13th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $181.00 price objective on shares of Johnson & Johnson in a research note on Wednesday, February 28th. Raymond James lifted their price objective on Johnson & Johnson from $172.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 3rd. Finally, Morgan Stanley decreased their target price on Johnson & Johnson from $170.00 to $169.00 and set an “equal weight” rating for the company in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Johnson & Johnson currently has an average rating of “Moderate Buy” and a consensus target price of $177.31.
Check Out Our Latest Stock Report on Johnson & Johnson
Johnson & Johnson Stock Performance
Shares of JNJ stock opened at $158.19 on Monday. The stock has a market capitalization of $381.20 billion, a PE ratio of 11.45, a price-to-earnings-growth ratio of 2.66 and a beta of 0.53. Johnson & Johnson has a 52-week low of $144.95 and a 52-week high of $175.97. The stock’s 50-day moving average price is $158.58 and its 200 day moving average price is $156.63. The company has a quick ratio of 0.91, a current ratio of 1.16 and a debt-to-equity ratio of 0.38.
Johnson & Johnson (NYSE:JNJ – Get Free Report) last issued its quarterly earnings results on Tuesday, January 23rd. The company reported $2.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.28 by $0.01. The firm had revenue of $21.40 billion for the quarter, compared to analysts’ expectations of $21.02 billion. Johnson & Johnson had a return on equity of 37.27% and a net margin of 37.79%. The firm’s revenue for the quarter was down 9.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.35 EPS. As a group, equities research analysts forecast that Johnson & Johnson will post 10.65 EPS for the current year.
Johnson & Johnson Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 5th. Shareholders of record on Tuesday, February 20th were given a dividend of $1.19 per share. This represents a $4.76 annualized dividend and a yield of 3.01%. The ex-dividend date …
Read More: Johnson & Johnson (NYSE:JNJ) Shares Sold by Future Financial Wealth Managment